Ardsley Advisory Partners LP purchased a new position in Asana, Inc. (NYSE:ASAN - Free Report) in the 4th quarter according to its most recent filing with the Securities and Exchange Commission The firm purchased 25,000 shares of the company's stock Other large investors also recently bought and sold shares of the company PDT Partners LLC purchased a new position in Asana during the fourth quarter valued at $570,000 Schonfeld Strategic Advisors LLC purchased a new stake in Asana during the 4th quarter valued at $1,892,000 Northern Trust Corp lifted its holdings in Asana by 2.3% in the fourth quarter Northern Trust Corp now owns 811,316 shares of the company's stock valued at $16,445,000 after acquiring an additional 18,599 shares during the period Tudor Investment Corp ET AL purchased a new position in shares of Asana in the fourth quarter worth approximately $5,396,000 Quarry LP purchased a new position in shares of Asana during the 4th quarter worth $29,000 26.21% of the stock is owned by hedge funds and other institutional investors A number of analysts have recently issued reports on the stock Scotiabank reduced their price objective on shares of Asana from $18.00 to $12.00 and set a "sector perform" rating for the company in a research note on Tuesday Baird dropped their target price on shares of Asana from $23.00 to $13.00 and set a "neutral" rating for the company in a research report on Tuesday cut their target price on shares of Asana from $15.00 to $13.00 and set an "underweight" rating for the company in a research note on Tuesday DA Davidson reduced their target price on Asana from $20.00 to $12.00 and set a "neutral" rating on the stock in a report on Tuesday Morgan Stanley decreased their price objective on Asana from $15.00 to $14.00 and set an "equal weight" rating on the stock in a report on Wednesday Two analysts have rated the stock with a sell rating nine have issued a hold rating and four have given a buy rating to the company Asana has a consensus rating of "Hold" and an average target price of $15.53 Get Our Latest Stock Analysis on ASAN Shares of ASAN traded down $0.22 during mid-day trading on Monday 1,001,723 shares of the company's stock traded hands compared to its average volume of 2,737,128 The company has a debt-to-equity ratio of 0.17 a current ratio of 1.49 and a quick ratio of 1.49 The stock's 50-day moving average is $15.48 and its two-hundred day moving average is $17.62 has a 12 month low of $11.05 and a 12 month high of $27.77 The stock has a market cap of $3.74 billion insiders acquired 2,074,507 shares of company stock worth $30,025,743 and sold 389,842 shares worth $7,820,003 63.97% of the stock is owned by company insiders MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on.. While Asana currently has a Hold rating among analysts top-rated analysts believe these five stocks are better buys View The Five Stocks Here Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat Click the link below to get your free copy Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools View source version on businesswire.com: https://www.businesswire.com/news/home/20250501466105/en/ Already have an account? Login Healthcare Asia Magazine website works best with Javascript enabled Please enable your javascript and reload the page The centre will leverage a system designed for treatment-resistant cancers Asan Medical Center (AMC) has announced plans to establish South Korea’s largest heavy ion therapy facility to expand personalised treatment options for hard-to-treat cancers The facility will be constructed on AMC’s Pungnap-dong campus in Seoul’s Songpa District with a planned floor area of 40,880㎡ It will include two rotating gantry treatment systems and one fixed beam treatment system To facilitate the introduction of a heavy ion therapy system the centre signed an agreement with Toshiba ESS and DK Medical Solutions launching full-scale preparations to begin operations by 2031 The facility will use the system to treat cancers that are resistant to conventional therapies it will also cover more common conditions such as prostate AMC plans to adopt a next-generation multi-ion source The multi-ion source approach is expected to reduce damage to healthy tissue with potential applications for paediatric cancer care Please try using other words for your search or explore other sections of the website for relevant information Our team is working diligently to resolve the issue Thank you for your patience and understanding The implied volatility in the call contract example above is 115% we calculate the actual trailing twelve month volatility (considering the last 250 trading day closing values as well as today's price of $16.29) to be 74% For more put and call options contract ideas worth looking at The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq This data feed is not available at this time These symbols will be available throughout the site during your session These instruments will be available throughout the site during your session Smart Portfolio is supported by our partner TipRanks. By connecting my portfolio to TipRanks Smart Portfolio I agree to their Terms of Use Asan Medical Center has developed a voice-based clinical documentation system powered by a large language model The system automatically records and analyses conversations – including identifying symptoms and classifying diseases – between and among staff and patients in near real-time It also creates patients' medical records on the spot which are automatically saved to AMIS 3.0 Installed on the emergency cart's tablet computer it can also be used during emergency responses The LLM was trained with "tens of thousands of hours" of clinical voice data covering various specialty medical terminologies To improve the scribe's voice recognition capability a dedicated microphone is used to filter background noise and calculate speakers' vocal range precisely First developed in 2023 and piloted in orthopaedic and plastic surgery outpatient clinics the AI scribe runs live across 16 AMC departments The hospital plans to expand the scribe's scope of use gradually Touted to be a first among hospitals in South Korea the clinical scribe was built to assist in improving medical record accuracy and support making precise treatment plans It also helps ensure patient safety by not missing out details or information particularly during urgent medical situations The development of the generative AI-based voice scribe is part of many projects enabling digital healthcare at one of South Korea's biggest hospitals. The foundational IT infrastructure running these projects, which include digital pathology and robot process automation, was validated at Stage 7 of the globally recognised HIMSS Infrastructure Adoption Model late last year AMC also applied AI in its recently launched web portal for international patients automatically translating eight major world languages and supporting data management and verification "With the AI-based voice recognition system for medical treatment we can effectively record and store a large amount of voice-based information that often gets lost during the treatment process," said Dr Young-Hak Kim director of AMC Health Innovation Big Data Center "Accurate symptom information reflecting the voices of medical staff and patients can be the basis for improving the quality of medical care and providing personalised treatment," he added © 2025 MobiHealthNews is a publication of HIMSS Media The latest news in digital health delivered daily to your inbox PDT Partners LLC acquired a new stake in Asana, Inc. (NYSE:ASAN - Free Report) during the 4th quarter according to its most recent filing with the Securities & Exchange Commission The fund acquired 28,100 shares of the company's stock Other hedge funds also recently modified their holdings of the company Arrowstreet Capital Limited Partnership bought a new stake in shares of Asana in the fourth quarter valued at about $38,966,000 Paradice Investment Management LLC acquired a new stake in Asana in the 4th quarter worth about $22,507,000 Voya Investment Management LLC boosted its holdings in Asana by 8.1% in the 4th quarter Voya Investment Management LLC now owns 12,539,038 shares of the company's stock valued at $254,166,000 after purchasing an additional 937,726 shares during the period Connor Clark & Lunn Investment Management Ltd acquired a new position in shares of Asana during the 4th quarter worth approximately $11,781,000 Trexquant Investment LP bought a new position in shares of Asana during the fourth quarter worth approximately $11,391,000 Institutional investors and hedge funds own 26.21% of the company's stock Several brokerages recently issued reports on ASAN UBS Group cut their price target on Asana from $18.00 to $14.00 and set a "neutral" rating for the company in a research note on Tuesday Scotiabank reduced their target price on Asana from $18.00 to $12.00 and set a "sector perform" rating on the stock in a report on Tuesday Baird dropped their price target on Asana from $23.00 to $13.00 and set a "neutral" rating for the company in a research note on Tuesday JMP Securities set a $22.00 price objective on shares of Asana in a research note on Tuesday Morgan Stanley dropped their target price on shares of Asana from $15.00 to $14.00 and set an "equal weight" rating for the company in a research report on Wednesday Two investment analysts have rated the stock with a sell rating nine have given a hold rating and four have assigned a buy rating to the stock the company currently has a consensus rating of "Hold" and a consensus target price of $15.53 Read Our Latest Report on Asana insiders bought 2,074,507 shares of company stock worth $30,025,743 and sold 389,842 shares worth $7,820,003 63.97% of the stock is currently owned by corporate insiders NYSE:ASAN traded down $0.22 on Monday 1,001,723 shares of the stock traded hands compared to its average volume of 2,737,145 a quick ratio of 1.49 and a debt-to-equity ratio of 0.17 has a 1-year low of $11.05 and a 1-year high of $27.77 The company's 50 day moving average is $15.55 and its 200-day moving average is $17.59 The firm has a market capitalization of $3.74 billion a price-to-earnings ratio of -14.33 and a beta of 1.21 Hsbc Holdings PLC raised its position in Asana, Inc. (NYSE:ASAN - Free Report) by 941.4% in the fourth quarter according to its most recent disclosure with the SEC The firm owned 136,447 shares of the company's stock after acquiring an additional 123,345 shares during the period Hsbc Holdings PLC owned approximately 0.06% of Asana worth $2,797,000 as of its most recent filing with the SEC Other institutional investors have also recently bought and sold shares of the company Arrowstreet Capital Limited Partnership bought a new position in Asana during the fourth quarter valued at $38,966,000 First Trust Advisors LP grew its position in Asana by 17.6% during the fourth quarter First Trust Advisors LP now owns 1,743,981 shares of the company's stock worth $35,350,000 after buying an additional 261,298 shares in the last quarter Paradice Investment Management LLC bought a new stake in Asana during the fourth quarter valued at approximately $22,507,000 increased its holdings in shares of Asana by 105.6% in the 3rd quarter now owns 832,598 shares of the company's stock worth $9,650,000 after buying an additional 427,576 shares during the last quarter Bank of New York Mellon Corp lifted its stake in Asana by 1.5% during the fourth quarter Bank of New York Mellon Corp now owns 805,649 shares of the company's stock worth $16,331,000 after purchasing an additional 11,896 shares during the last quarter insiders have bought 2,074,507 shares of company stock worth $30,025,743 and have sold 389,842 shares worth $7,820,003 ASAN traded down $0.15 during trading on Monday The stock had a trading volume of 447,962 shares compared to its average volume of 2,735,028 The stock has a 50 day simple moving average of $15.55 and a two-hundred day simple moving average of $17.59 a quick ratio of 1.49 and a current ratio of 1.49 has a twelve month low of $11.05 and a twelve month high of $27.77 The company has a market capitalization of $3.76 billion A number of research analysts have recently issued reports on the company JMP Securities set a $22.00 price objective on Asana in a research note on Tuesday Scotiabank lowered their price objective on Asana from $18.00 to $12.00 and set a "sector perform" rating for the company in a research report on Tuesday Citigroup lifted their target price on shares of Asana from $16.00 to $20.00 and gave the stock a "neutral" rating in a research note on Thursday dropped their price target on shares of Asana from $15.00 to $13.00 and set an "underweight" rating for the company in a research report on Tuesday Jefferies Financial Group dropped their target price on shares of Asana from $19.00 to $15.00 and set a "hold" rating for the company in a report on Tuesday nine have issued a hold rating and four have assigned a buy rating to the company the company has a consensus rating of "Hold" and a consensus target price of $15.53 View Our Latest Stock Report on Asana MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued Enter your email address and below to see which companies made the list Marshall Wace LLP purchased a new stake in shares of Asana, Inc. (NYSE:ASAN - Free Report) in the fourth quarter The institutional investor purchased 84,529 shares of the company's stock Several other institutional investors have also added to or reduced their stakes in ASAN Arrowstreet Capital Limited Partnership bought a new stake in Asana in the fourth quarter valued at $38,966,000 Paradice Investment Management LLC purchased a new position in shares of Asana during the fourth quarter valued at about $22,507,000 increased its position in shares of Asana by 105.6% during the third quarter now owns 832,598 shares of the company's stock valued at $9,650,000 after buying an additional 427,576 shares during the period Bank of New York Mellon Corp raised its stake in Asana by 1.5% in the fourth quarter Bank of New York Mellon Corp now owns 805,649 shares of the company's stock worth $16,331,000 after buying an additional 11,896 shares in the last quarter lifted its holdings in Asana by 7.6% in the fourth quarter now owns 694,792 shares of the company's stock worth $14,083,000 after buying an additional 48,831 shares during the period Hedge funds and other institutional investors own 26.21% of the company's stock Shares of ASAN traded up $0.21 during trading hours on Friday The stock had a trading volume of 1,511,504 shares compared to its average volume of 2,744,097 The firm has a market capitalization of $3.79 billion The stock has a fifty day moving average price of $15.55 and a 200 day moving average price of $17.59 Corporate insiders own 63.97% of the company's stock A number of research analysts have weighed in on ASAN shares JMP Securities set a $22.00 target price on Asana in a report on Tuesday Morgan Stanley decreased their price objective on Asana from $15.00 to $14.00 and set an "equal weight" rating for the company in a report on Wednesday Bank of America reduced their target price on shares of Asana from $30.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday Scotiabank lowered their price target on shares of Asana from $18.00 to $12.00 and set a "sector perform" rating for the company in a research report on Tuesday Jefferies Financial Group cut their price objective on shares of Asana from $19.00 to $15.00 and set a "hold" rating on the stock in a report on Tuesday nine have issued a hold rating and four have assigned a buy rating to the stock the stock currently has a consensus rating of "Hold" and a consensus target price of $15.53 Read Our Latest Analysis on ASAN MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. © MarketBeat Media, LLC 2010-2025. All rights reserved. accurate diagnoses at ASAN Medical CenterFeaturing Heounjeong Go PhD March 25 2025 7 min read Customer storyPathologyDiagnostic and clinical informaticsHow do you meet the rise in cancer cases with fast accurate pathology diagnoses while staffing levels remain constant in the pathology department ASAN has been diagnosing cases using digital pathology for all surgical cases and consultation on cases from other hospitals The journey to digital pathology started years ago for ASAN Heounjeong Go feels it was well worth it for the benefits the institution gained increased diagnostic confidence and a better experience for pathologists and consulting physicians ASAN Medical Center in Seoul is the largest private hospital in South Korea serving more than one million inpatients and 3.2 million outpatients yearly focused on cancer treatment and organ transplants Heounjeong Go heads a pathology department of 27 professors and approximately 15 residents and fellows Go feels it was well worth it for the benefits the institution gained ASAN produces a high volume of slides (approximately 900,000 pathology slides yearly) and diagnoses approximately 130,000 surgical pathology cases While the number of cases continues to increase staffing in the pathology department remains constant requiring improved workforce efficiency for timely diagnosis and smooth consultation This increased volume also creates challenges for data management The introduction of digital pathology at ASAN has resulted in decreased time to diagnosis even though the number of diagnoses increased and the number of pathologists has remained unchanged average diagnosis time decreased by 19 hours and 51 minutes (-27.6%) with digital pathology and by 1 hour and 28 minutes (-2.93%) for immunopathology when the method of specifying ROI was performed using a digital pathology system the test time per case was reduced by about 1 hour Because people are living longer with cancer it is becoming more common for those patients to undergo repeat biopsies or surgeries during follow-up care which often requires review of pathology slides made years ago locating and retrieving those physical slides required extra time staining quality may have faded on old slides reducing image quality and diagnostic confidence It is difficult to make precise annotations for diagnosis using physical slides it can be difficult to locate and review those slides in a timely fashion When preparing for conferences or writing papers photos must be taken with a camera to present results storing physical slides requires significant space in the facility ASAN decided to digitize all newly produced slides EMR and image management systems are tightly integrated for greater diagnostic efficiency and integrated systems send all pathological ancillary test results from the pathology department to the digital pathology server allowing all test results to be managed by surgical pathology case ASAN has implemented an interface for AI-based algorithms and is building a platform that can provide de-identified and pseudonymized diagnosis slides for research and external consultation ASAN uses an AI-based program that takes less than one minute per case to evaluate the morphometric analysis (previously a resident would spend two hours every day to evaluate morphometry) reimbursement is greater for AI-assisted morphometry there were no similar reference models for an institution as large as ASAN and most other institutions had only partially implemented digital pathology starting in 2017 and finalized by the end of 2019 reaching an agreement with hospital administration to proceed ASAN created a task force to begin the project building the necessary interfaces for a year followed by another year of trial operation It took approximately five years to fully implement digital pathology at ASAN Go addressed concerns about digital implementation by identifying difficulties in the analog workflow for diagnosis and found that a major obstacle was in locating and reviewing previously made physical slides Go was able to demonstrate a number of benefits Slide access is easy using the digital system Security of patient data is enhanced when using digital slides to consult with other hospitals because no physical slides are transported from one location to another Pathologists were concerned with the ability to use new technology Go provided one-on-one training so that her team was comfortable with the technology Digital slides are easier to view vs the microscope (younger pathologists are very comfortable with computer use and older technologists appreciate the enlarged view) The unified barcode system has eliminated the chance of misidentifying physical slides and so that the risk is reduced to nearly 0% creating an error-free system of identification.* The hospital uses a 1G network and the pathology department operates on a separate 10G network for uploading and downloading data ASAN prides itself in short turnaround times for pathology slides delivering diagnosis in 1.5 days for biopsy specimens and 3.5 days for resection slides Go says that ASAN has highly efficient workforce utilization compared to other institutions Initial concerns concerned productivity and efficiency--could they be maintained after adopting digital pathology because of the extra workflow step of scanning slides Go decided to re-evaluate all processes from the perspective of digitalization and optimize them for digital pathology and made the bold decision to fully implement the digital pathology system at once rather than in stages to avoid the inefficiencies of managing workflow that was partially digital and partially analog ASAN set up an interface that allows directly viewing of previous cases of whole slide images from the EMR case management screen The institution also changed the entire physical environment of the pathology department - including equipment workspaces and conference areas - to be conducive to digital workflow Molecular work is now more efficient because of the ability to draw annotations for DNA extraction directly on the slide which previously required 1-2 days for a glass slide Go says that pathologists prefer digital viewing to viewing with a microscope because of the ease of workflow and that the scanned images are able to be viewed at greater than 40X power which is helpful in identifying small particles or organisms The ease of sharing and discussing digital images aids collaboration with other clinicians Go points out some of the past difficulties in diagnosing in the analog era they would all gather together and have a separate meeting or they would come to the office one by one with slides and ask for opinions Because these cases take significant time and effort and sometimes the diagnosis is made without sufficient consultation you can easily consult multiple pathologists using the simple IMS messenger app and have those pathologists access and view your case at the same time sharing opinions even if you are not in the same room This is not limited to just an opinion about the diagnosis but can also include additional tests that are needed an interpretation of the tests and the patient's clinical situation This allows for a more specific diagnosis that can be much more helpful in the patient's treatment.” This IMS collaboration feature that allows pathologists to connect through chat sessions and case link sharing can also be used for purposes beyond diagnosis (e.g. panel discussions and educational sessions) This allows pathologists to review digital slides in real time with other users from anywhere Go imagines that the field of digital pathology can be expanded to include frozen sections and cytology specimens a system that manages all ancillary test images and the creation of a prognostic cancer screening and grading system “I think AI will definitely benefit productivity and diagnostic efficiency if we can use more models for a variety of purposes in addition to the morphometry we currently use,” says Dr in the prostate screening model that is currently being used in multiple institutions each of the 12 cores must be evaluated for diagnosis number of tumor foci and neural tissue infiltration I think the accuracy and productivity of the diagnosis will increase dramatically.” Go notes the importance of a user-centered approach to digital pathology transformation it is crucial to think about how things will change from the perspective of the pathologist who will actually use it Implementers tend to focus on the technical aspect but users care most about how much easier their work will become with the digital system.” Heounjeong GoHead of Pathology DepartmentASAN Medical Center University of Ulsan College of MedicineGoing fully digital from the start made more sense for ASAN because both hybrid workflow and a fully digital approach would require the same scope of infrastructure development and fully digital workflow allowed for a reduction in time to diagnosis and pathologists can start reading two hours earlier than before allowing them the time to focus on other tasks She points out tight integration of the EHR and image management system (IMS) is essential and that the entire workflow needs to be transformed because traditional pathology processes are designed for the analog method Philips is an experienced and trusted end-to-end partner of choice before during and after digital transformation with workflow planning training and support for a smooth transformation to digital pathology Philips demonstrated that it is committed to quality and the Philips team works to innovate in digital pathology by truly listening to the pathologists' feedback Digital pathology at ASAN has led to decreased time to diagnoses supports increased clinical confidence for clinicians and is valued by the department for its positive effect on workflow and work-life balance for staff